Subscribe To

Price Alert Latest News Economic Calendar News

GRTS / Gritstone bio Inc. (GRTS) CEO Andrew Allen on Q2 2022 Results - Earnings Call Transcript

Gritstone bio Inc. (NASDAQ:GRTS ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants George MacDougall - Director, Investor Relations and Corporate Communications Andrew Allen - Co-Founder, President, CEO and Director Vassiliki Economides - Executive VP and CFO Karin Jooss - Head of Research and Development Conference Call Participants Marc Frahm - Cowen Tom Shrader - BTIG Sean Lee - H.C. Wainwright Corinne Jenkins - Goldman Sachs Umer Raffat - Evercore Operator Welcome to Gritstone bio Second Quarter 2022 Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Gritstone

Inc

GRTS

Andrew

Allen

2022

Results

Earnings

grts

Transcript

Stock

Posted: Aug 6 2022, 16:44

Author Name: Seeking Alpha

GRTS News

By Zacks Investment Research
October 16, 2023

Gritstone bio Inc. (GRTS) Upgraded to Buy: What Does It Mean for the Stock?

Gritstone bio Inc. (GRTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might d

By Seeking Alpha
October 14, 2023

Gritstone bio: Renewed Excitement For Its COVID-19 Vaccine

GRTS's COVID-19 vaccine may produce more durable immunity than current mRNA vaccines, according to data from phase 1 studies. GRTS has secured a $433

By Seeking Alpha
May 11, 2023

Gritstone bio, Inc. (GRTS) Q1 2023 Earnings Call Transcript

Gritstone bio, Inc. (NASDAQ:GRTS ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 AM ET Company Participants George MacDougall - Director, Investo

By Zacks Investment Research
May 11, 2023

Gritstone bio Inc. (GRTS) Reports Q1 Loss, Lags Revenue Estimates

Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to l

By Seeking Alpha
April 23, 2023

Gritstone bio: Q4 2023 Data Readout Is Going To Be Major Inflection Point

Gritstone bio: Q4 2023 Data Readout Is Going To Be Major Inflection Point.

By Seeking Alpha
March 9, 2023

Gritstone bio Inc. (GRTS) Q4 2022 Results - Earnings Call Transcript

Gritstone bio Inc. (NASDAQ:GRTS ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ET Company Participants George MacDougall - Director, Investo

By Zacks Investment Research
March 9, 2023

Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates

Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 3.23% and 38.38%, respectively, for the quarter ended December 2022. Do the numb

By GlobeNewsWire
January 18, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop th

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.